🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, single-arm study to evaluate the efficacy, safety, and ...
Status
Unknown
Location
MD Anderson Cancer Center
Start Date
2022-05-01
Trial ID
NCT05274997
Treatments Being Tested
This is a single arm, open label, national multicenter clinical study inclu...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2024-08-13
Trial ID
NCT06592170
Treatments Being Tested
This is a single arm, open label, national multicenter clinical study inclu...
Status
Not Yet Recruiting
Location
The Second Hospital Dalian Medical University
Start Date
2024-05-01
Trial ID
NCT06324994
Treatments Being Tested
Pure red cell aplasia (PRCA) is a syndrome characterized by normocytic norm...
Status
Not Yet Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-09-01
Trial ID
NCT07031115
Treatments Being Tested
The patients diagnosed with relapsed/refractory or advanced NK/T-cell Lymph...
Status
Recruiting
Location
Liang Wang
Start Date
2024-04-14
Trial ID
NCT06376721
Treatments Being Tested
HDAC inhibitor chidamide and PI3K inhibitor linperlisib has shown clinical ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-07-01
Trial ID
NCT06037239
Treatments Being Tested
This is a multicenter, non-interventional and observational real-world stud...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-05
Trial ID
NCT05863871
Treatments Being Tested
Indolent T/NK-cell lymphomas are a heterogeneous group of lymphoproliferati...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2024-08-10
Trial ID
NCT06530550
Treatments Being Tested
To evaluate the efficacy and safety of Linperlisib combined with standard i...
Status
Recruiting
Location
Institute of Hematology & Blood Disease Hospital
Start Date
2024-05-28
Trial ID
NCT06489808
This is a prospective, multicenter, single-arm, pilot study. The aim of thi...
Status
Terminated
Location
Zhoukou Central Hospital
Start Date
2023-01-13
Trial ID
NCT05676697
Treatments Being Tested